Annals of internal medicine
-
Comment
In overweight or obese adults without diabetes, semaglutide increased weight loss and GI disorders.
Wilding JPH, Batterham RL, Calanna S, et al. Once-weekly semaglutide in adults with overweight or obesity. N Engl J Med. 2021;384:989. 33567185.
-
Use of high-flow nasal oxygen (HFNO) for treatment of adults with acute respiratory failure (ARF) has increased. ⋯ American College of Physicians. (PROSPERO: CRD42019146691).